Kobo Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported net loss was INR 11.91 million compared to INR 13.48 million a year ago. Basic loss per share from continuing operations was INR 0.5 compared to INR 0.57 a year ago.
For the nine months, revenue was INR 0.152 million compared to INR 0.166 million a year ago. Net loss was INR 37.6 million compared to INR 48.09 million a year ago. Basic loss per share from continuing operations was INR 1.58 compared to INR 2.02 a year ago.